Search Page

1

Cite

Share

HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.

Kimball AB, Sobell JM, Zouboulis CC, Gu Y, Williams DA, Sundaram M, Teixeira HD, Jemec GB. Kimball AB, et al. Among authors: sobell jm. J Eur Acad Dermatol Venereol. 2016 Jun;30(6):989-94. doi: 10.1111/jdv.13216. Epub 2015 Jul 22. J Eur Acad Dermatol Venereol. 2016. PMID: 26201313 Free PMC article. Clinical Trial.

Cite

Share

2

Cite

Share

Introduction. Dermatitis.

Sikora BC, Sobell JM. Sikora BC, et al. Among authors: sobell jm. Semin Cutan Med Surg. 2013 Sep;32(3):131. doi: 10.12788/j.sder.0033. Semin Cutan Med Surg. 2013. PMID: 24175399 No abstract available.

Cite

Share

3

Cite

Share

Therapeutic development in psoriasis.

Sobell JM, Leonardi CL. Sobell JM, et al. Semin Cutan Med Surg. 2014 Jun;33(4 Suppl):S69-72. doi: 10.12788/j.sder.0098. Semin Cutan Med Surg. 2014. PMID: 25268599 Review.

Cite

Share

4

Cite

Share

Using targeted therapies for inflammatory dermatoses.

Sobell JM. Sobell JM. Semin Cutan Med Surg. 2018 Sep;37(3):133. doi: 10.12788/j.sder.2018.050. Semin Cutan Med Surg. 2018. PMID: 30215628 No abstract available.

Cite

Share

5

Cite

Share

The role of TNF inhibitors in psoriatic disease.

Mandell BF, Sobell JM. Mandell BF, et al. Among authors: sobell jm. Semin Cutan Med Surg. 2014 Jun;33(4 Suppl):S64-8. doi: 10.12788/j.sder.0097. Semin Cutan Med Surg. 2014. PMID: 25268598 Review.

Cite

Share

6

Cite

Share

Overview of biologic agents in medicine and dermatology.

Sobell JM. Sobell JM. Semin Cutan Med Surg. 2005 Mar;24(1):2-9. doi: 10.1016/j.sder.2005.01.007. Semin Cutan Med Surg. 2005. PMID: 15900793 Review.

Cite

Share

7

Cite

Share

Defining drug-free remission of skin disease in patients with plaque psoriasis.

Armstrong AW, Blauvelt A, Crowley JJ, Gordon KB, Krueger GG, Krueger JG, Sobell JM, Strober BE, Srivastava B, Menter A. Armstrong AW, et al. Among authors: sobell jm. Br J Dermatol. 2020 Jun;182(6):1484-1487. doi: 10.1111/bjd.18694. Epub 2020 Jan 29. Br J Dermatol. 2020. PMID: 31705649 No abstract available.

Cite

Share

8

Cite

Share

Systemic therapies for psoriasis: understanding current and newly emerging therapies.

Sobell JM, Hallas SJ. Sobell JM, et al. Semin Cutan Med Surg. 2003 Sep;22(3):187-95. doi: 10.1016/S1085-5629(03)00042-7. Semin Cutan Med Surg. 2003. PMID: 14649586 Review.

Cite

Share

9

Cite

Share

Update on TNF Inhibitors in Dermatology.

Sobell JM. Sobell JM. Semin Cutan Med Surg. 2016 Jun;35(6 Suppl):S104-6. doi: 10.12788/j.sder.2016.033. Semin Cutan Med Surg. 2016. PMID: 27537073

Cite

Share

10

Cite

Share

Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis.

Ryan C, Sobell JM, Leonardi CL, Lynde CW, Karunaratne M, Valdecantos WC, Hendrickson BA. Ryan C, et al. Among authors: sobell jm. Am J Clin Dermatol. 2018 Jun;19(3):437-447. doi: 10.1007/s40257-017-0341-6. Am J Clin Dermatol. 2018. PMID: 29380251 Free PMC article. Clinical Trial.

Cite

Share